Florida Senate - 2022                        COMMITTEE AMENDMENT
       Bill No. CS for SB 1010
       
       
       
       
       
       
                                Ì920488JÎ920488                         
       
                              LEGISLATIVE ACTION                        
                    Senate             .             House              
                                       .                                
                                       .                                
                                       .                                
                                       .                                
                                       .                                
       —————————————————————————————————————————————————————————————————




       —————————————————————————————————————————————————————————————————
       The Committee on Appropriations (Gibson) recommended the
       following:
       
    1         Senate Amendment (with title amendment)
    2  
    3         Delete lines 28 - 69
    4  and insert:
    5         (b) “Health care provider” means a physician or physician
    6  assistant licensed under chapter 458 or chapter 459 or an
    7  advanced practice registered nurse registered under chapter 464.
    8         (c) “Uterine fibroid” means a noncancerous growth of the
    9  uterus that often appears during a woman’s childbearing years.
   10         (2) UTERINE FIBROID RESEARCH DATABASE.—
   11         (a) The department shall develop and maintain an electronic
   12  database consisting of information related to uterine fibroids.
   13  The purpose of the database is to encourage research relating to
   14  the diagnosis and treatment of uterine fibroids and to ensure
   15  that women are provided with the relevant information and health
   16  care necessary to prevent and treat uterine fibroids. The
   17  database must include, but need not be limited to, all of the
   18  following information:
   19         1. Incidence and prevalence of women diagnosed with uterine
   20  fibroids in this state.
   21         2. Demographic attributes of women diagnosed with uterine
   22  fibroids in this state.
   23         3. Treatments and procedures for uterine fibroids used by
   24  health care providers in this state.
   25         (b) A health care provider who diagnoses or treats a woman
   26  with uterine fibroids shall submit information relating to such
   27  diagnosis or treatment to the department in a form and manner
   28  prescribed by department rule for inclusion in the database.
   29  Such information may be submitted along with any reports or
   30  other information that the health care provider is required to
   31  submit to the department pursuant to state law.
   32         (c) The database may not include any personal identifying
   33  information of women diagnosed with or treated for uterine
   34  fibroids.
   35         (3) UTERINE FIBROID EDUCATION OUTREACH AND PUBLIC
   36  AWARENESS.—The department shall develop and include information
   37  related to uterine fibroids in its women’s health care
   38  educational materials currently made available to the public.
   39  The information must include, but need not be limited to, the
   40  following:
   41         (a) Possible risk factors for developing uterine fibroids.
   42         (b) Range of available treatment options that are
   43  considered alternatives to hysterectomy.
   44         Section 2. For the 2022-2023 fiscal year, the sums of
   45  $121,852 in recurring funds and $681,048 in nonrecurring funds
   46  from the General Revenue Fund are appropriated to the Department
   47  of Health and one full-time equivalent position with associated
   48  salary rate of 55,212 is authorized for the purpose of
   49  implementing this act.
   50  
   51  ================= T I T L E  A M E N D M E N T ================
   52  And the title is amended as follows:
   53         Delete lines 12 - 18
   54  and insert:
   55         identifying information; requiring the department to
   56         develop and include information related to uterine
   57         fibroids in certain literature currently made
   58         available to the public for a specified purpose;
   59         providing an appropriation and authorizing a position;
   60         providing an effective date.